Reuters logo
BRIEF-Immune Pharmac prices $18 mln public offering
October 19, 2017 / 1:12 PM / a month ago

BRIEF-Immune Pharmac prices $18 mln public offering

Oct 19 (Reuters) - Immune Pharmaceuticals Inc

* Immune Pharmaceuticals Inc announces pricing of $18,000,000 public offering of convertible preferred stock and warrants

* Immune Pharmaceuticals Inc - ‍offering will be comprised of units, priced at a public offering price of $1,000 per unit​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below